TSLA - Psychedelics Headlines: MDMA & Coping Skills In PTSD LSD's Perceived Risks Knowledge Gaps Surveys & More | Benzinga
Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.
See previous edition: Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
Research
-
Lykos Therapeutics (formerly MAPS PBC) published research results on the effects of MDMA-assisted therapy on emotional coping skills and self-experience in PTSD (read.)
-
Australian study "Potential therapeutic effects of an ayahuasca-inspired N, N-DMT and harmine formulation: a controlled trial in healthy subjects” (read.)
-
The antidepressant effects of vaporized DMT: a preliminary report in treatment-resistant depression (read.)
-
Chinese government-backed research on psilocybin’s cell-type-specific changes in the orbitofrontal cortex (read.)
-
Perceived risk of trying LSD in the U.S. from 2015 to 2019: Are Americans assessing LSD's risk profile more favorably? (read.)
-
New review on the potential of psychedelics for acquired brain injury treatment (read.)
-
Knowledge gaps in psychedelic medicalization: Clinical studies and regulatory aspects (read.)
-
Imperial College London’s psilocybin study for gamblers’ brain dysfunction reversion (read.)
-
"Coming back together: A qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs,” research led by Jules Evans (preprint.)
-
UC Berkeley’s Center for the Science of Psychedelics is opening applications for research proposals on "Psychedelics in Society and Culture” (participate.)
-
Imperial College London’s psychedelic survey "The Breathwork Study 2024” (participate.)
-
Johns Hopkins’ new psilocybin research seeks participants in Baltimore with opioid use disorder opioid use (apply.)
-
University of Texas’ new psychedelic retreat research focused on women currently grieving the loss of a loved one (participate.)
Tune In, Get Smart
-
Jan. 31 and Feb. 1, the FDA’s Reagan-Udall Foundation will hold a virtual public workshop titled "Advancing Psychedelic Clinical Study Design" (participate.)
-
DoubleBlind’s free workshop on Tripping for Partners with Dr. ...